Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study

SARI-RAF Study Group members

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds